a physician a building location a clinical trial a department
menu
BCM - Baylor College of Medicine

Giving life to possible

Baylor College of Medicine News

Breast Cancer News

2012 Pink Ribbon House Fundraiser kicks offOct 4, 2011
Funds are raised through home tours, corporate and individual sponsorships and individual contributions.
Hereditary Breast and Ovarian Cancer Conference set Oct. 29Oct 4, 2011
Women who test positive for a mutation in the BRCA1 or BRCA2 genes are at a significantly higher risk of breast cancer and ovarian cancer.
Stress-induced mutagenesis part of spontaneous mutationAug 1, 2011
Baylor College of Medicine genetics professor Dr. Susan Rosenberg provides insights into how, when under stress, cell mutations increase.
MiMIC sleight-of-hand enables DNA manipulation in fruit flyJul 31, 2011
Baylor College of Medicine collaborated to develop a new tool called MiMIC to help tackle important DNA questions.
New McNair Scholar focuses research on how breast cancer spreadsJun 21, 2011
Newly named McNair Scholar Dr. Xiang Zhang's research focuses on breast cancer metastasis.
Hilsenbeck named Fellow of American Statistical AssociationMay 19, 2011
Baylor College of Medicine professor named Fellow of the American Statistical Association.
Certain breast cancer patients may benefit from combined HER-2 targeted treatment without chemotherapyMay 18, 2011
Researchers find that certain breast cancer patients may benefit from a combination of treatments, may not need chemotherapy.
Breast progenitor cells form unique type of breast cancerMay 3, 2011
BCM researchers among those to target a cancer-causing gene to different types of normal cells in a mouse breast.
Courage, dedication motivate Avon walkers every step of their personal journeyApr 18, 2011
Read stories and see a photo slideshow from the 2011 Avon walk.
Loss of Rho GDI sparks resistance to treatment, opens doorway for metastasis studies in hormone receptor positive breast cancerMar 30, 2011
Study represents first model researchers can use to study estrogen receptor positive breast cancer that has metastasized.